5AM Venture Management, LLC holdings history

Add to watchlist

40 is the total number of securities 5AM Venture Management, LLC has owned. The longest 5AM Venture Management, LLC has owned a single stock is 16 quarters.

5AM Venture Management, LLC historical holdings. Includes current and past holdings.
Period Weighting Quarter
TickerNameLongestShortestMin.Avg.Max.FirstLatest↓ Count
FIXX HOMOLOGY MEDICINES INC16161.00%8.80%26.64%Q4 2019Q3 202316
ARVN ARVINAS INC16161.81%6.34%14.30%Q4 2019Q3 202316
CRNX Crinetics Pharmaceutic...16163.24%5.38%12.75%Q4 2019Q3 202316
SCPH SCPHARMACEUTICALS INC16162.46%4.87%7.51%Q4 2019Q3 202316
CDTX CIDARA THERAPEUTICS INC16160.14%0.76%1.66%Q4 2019Q3 202316
IDYA IDEAYA BIOSCIENCES INC14143.05%6.55%11.44%Q4 2019Q1 202314
VOR VOR BIOPHARMA INC11113.88%15.32%51.94%Q1 2021Q3 202311
CABA CABALETTA BIO INC11110.54%6.73%14.17%Q4 2019Q2 202211
AKUS AKOUOS INC10104.29%13.22%27.70%Q2 2020Q3 202210
IMPL IMPEL PHARMACEUTICALS INC10100.36%3.68%7.14%Q2 2021Q3 202310
RALLYBIO CORP993.52%7.37%14.96%Q3 2021Q3 20239
RNA AVIDITY BIOSCIENCES INC991.22%2.04%3.97%Q3 2021Q3 20239
ENTRADA THERAPEUTICS INC889.04%14.85%20.04%Q4 2021Q3 20238
FVAM 5 01 ACQUISITION CORP880.66%0.83%1.25%Q4 2020Q3 20228
ISEE IVERIC BIO INC771.75%2.36%3.78%Q3 2021Q1 20237
COGT COGENT BIOSCIENCES INC771.16%2.16%2.52%Q1 2022Q3 20237
JANX JANUX THERAPEUTICS INC771.16%1.70%2.80%Q2 2021Q4 20227
APRE APREA THERAPEUTICS INC660.57%15.75%30.70%Q4 2019Q1 20216
PEAR THERAPEUTICS INC661.09%10.39%21.68%Q4 2021Q1 20236
PHVS PHARVARIS N V660.86%2.13%3.53%Q2 2022Q3 20236
VRDN VIRIDIAN THERAPEUTICS INC551.66%1.91%2.36%Q3 2022Q3 20235
CINCOR PHARMA INC4416.31%21.05%31.05%Q1 2022Q4 20224
DISC MEDICINE INC443.14%4.42%5.93%Q4 2022Q3 20234
ANAB ANAPTYSBIO INC441.81%2.16%2.98%Q4 2022Q3 20234
ENLIVEN THERAPEUTICS INC3320.28%27.41%32.47%Q1 2023Q3 20233
MOONLAKE IMMUNOTHERAPE...330.21%3.30%5.14%Q1 2023Q3 20233
VKTX VIKING THERAPEUTICS INC331.49%1.90%2.36%Q1 2023Q3 20233
SPRB SPRUCE BIOSCIENCES INC331.27%1.38%1.54%Q1 2023Q3 20233
MRSN MERSANA THERAPEUTICS INC330.48%0.93%1.24%Q1 2023Q3 20233
ZNTL ZENTALIS PHARMACEUTICA...222.83%3.14%3.44%Q2 2023Q3 20232
CLDX CELLDEX THERAPEUTICS I...222.46%2.54%2.62%Q2 2023Q3 20232
MRTX MIRATI THERAPEUTICS INC221.73%2.07%2.41%Q2 2023Q3 20232
FGEN FIBROGEN INC220.97%1.87%2.76%Q4 2022Q1 20232
GHRS GH RESEARCH PLC220.45%0.81%1.17%Q2 2023Q3 20232
DIANTHUS THERAPEUTICS INC115.79%5.79%5.79%Q3 2023Q3 20231
TYRA BIOSCIENCES INC111.63%1.63%1.63%Q3 2023Q3 20231
RXDX PROMETHEUS BIOSCIENCES...111.27%1.27%1.27%Q2 2022Q2 20221
SBTX SILVERBACK THERAPEUTIC...110.34%0.34%0.34%Q3 2021Q3 20211
GMTX GEMINI THERAPEUTICS INC110.16%0.16%0.16%Q3 2022Q3 20221
Viveve Medical, Inc.110.00%0.00%0.00%Q4 2019Q4 20191
 Download

The securities at the top of the list , including HOMOLOGY MEDICINES INC, ARVINAS INC, and Crinetics Pharmaceuticals, Inc., are the highest-conviction holdings of 5AM Venture Management, LLC.

The conviction is calculated by counting the number of quarters a security has been reported by 5AM Venture Management, LLC. The higher the number, the higher the conviction and longer the holding period.

This page lists all the securities that 5AM Venture Management, LLC owns currently or has owned in the past.